Cerebra is making its patented ORP (Odds Ratio Product) technology, which has been validated as a measure of sleep depth, available to qualified researchers for free through its newly launched MY Sleep Scoring application programming interface (API).
ORP microanalyzes EEG signals to provide greater insight into brain activity during sleep. Over two dozen peer-reviewed scientific articles have been published on ORP, and some of the most important findings have linked it to understanding the impact of sleep quality on adherence to CPAP therapy, insomnia and obstructive sleep apnea phenotyping, and individual risk of motor vehicle accidents, according to a release from the company.
The MY Sleep Scoring API enables seamless and automated processing of polysomnography data, removing barriers to the use of ORP in clinical research. Cerebra is looking to work with qualified researchers to accelerate the clinical application of the technology in identifying and treating the underlying causes of disrupted sleep.
“My Sleep Scoring API gives researchers the ability to directly access Cerebra’s ORP metrics portfolio with greater customization and data transparency,” says Veronica Guadagni, PhD, director of sleep science for Cerebra, in a release. “Our scientific founder, Dr Magdy Younes, in a recently published state-of-the-art review on ORP, has identified a number of areas to further validate the use of ORP in clinical practice and we’re excited to open this opportunity up to the global research community.”
The first research collaboration utilizing the API tool has commenced with the team led by David Rapoport, MD, and Ankit Parekh, PhD, at the Icahn School of Medicine, Mount Sinai Hospital. The MY Sleep Scoring API will be used to process a large number of sleep studies. The ORP data will be analyzed to gain deeper insight into sleep and sleep disorders with the goal of further establishing it as a clinically relevant metric.